Pfizer Inc Announces Completion of the Tender Offer Relating to Outstanding Shares of Coley Pharmaceutical Group, Inc.
2007年12月31日 - 10:00PM
ビジネスワイヤ(英語)
Pfizer (NYSE:PFE) announced today that it has completed the cash
tender offer to purchase all of the outstanding shares of common
stock of Coley Pharmaceutical Group, Inc. (Nasdaq:COLY). The tender
offer expired, as scheduled, at midnight, Eastern time, on Friday,
December 28, 2007. The offer was not extended. A total of
24,050,054 shares of Coley common stock were validly tendered and
not withdrawn prior to the expiration of the offer, including
661,444 shares subject to guaranteed delivery procedures. Through
its indirect wholly owned subsidiary, Corvette Acquisition Corp.,
Pfizer has accepted for payment all validly tendered shares. The
shares accepted for payment, together with the shares previously
owned by Corvette Acquisition Corp., represent approximately 92.2
percent of Coley�s outstanding common shares. As the final step of
the acquisition process, Pfizer intends to consummate a merger in
which remaining Coley shareholders will receive the same $8.00 cash
price per share paid in the tender offer. Consummation of the
merger is expected to occur within the next several days. Following
the merger, Coley will become an indirect wholly owned subsidiary
of Pfizer.
Coley Pharmaceutical Grp. (MM) (NASDAQ:COLY)
過去 株価チャート
から 8 2024 まで 9 2024
Coley Pharmaceutical Grp. (MM) (NASDAQ:COLY)
過去 株価チャート
から 9 2023 まで 9 2024
Real-Time news about Coley Pharmaceutical Grp. (MM) (ナスダック市場): 0 recent articles
その他のPfizerニュース記事